[en] Abnormal subchondral bone remodeling leading to sclerosis is a main feature of osteoarthritis (OA), and osteomodulin (OMD), a proteoglycan involved in extracellular matrix mineralization, is associated with the sclerotic phenotype. However, the functions of OMD remain poorly understood, specifically in vivo. We used Omd knockout and overexpressing male mice and mutant zebrafish to study its roles in bone and cartilage metabolism and in the development of OA. The expression of Omd is deeply correlated with bone and cartilage microarchitectures affecting the bone volume and the onset of subchondral bone sclerosis and spontaneous cartilage lesions. Mechanistically, OMD binds to RANKL and inhibits osteoclastogenesis, thus controlling the balance of bone remodeling. In conclusion, OMD is a key factor in subchondral bone sclerosis associated with OA. It participates in bone and cartilage homeostasis by acting on the regulation of osteoclastogenesis. Targeting OMD may be a promising new and personalized approach for OA.
Research Center/Unit :
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE] d‐BRU - Dental Biomaterials Research Unit - ULiège [BE]
Disciplines :
Rheumatology
Author, co-author :
Zappia, Jérémie ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Tong, Qiao; School of Physiology, Pharmacology, and Neuroscience, University of Bristol, Bristol, UK
Van der Cruyssen, Renée; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium ; Laboratory for Molecular Immunology and Inflammation, Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
Cornelis, Frederique M F; Laboratory of Tissue Homeostasis and Disease, Skeletal Biology and Engineering Research Center, Department of Development and Regeneration, KU Leuven, Leuven, Belgium
Lambert, Cécile ; Université de Liège - ULiège > Département des sciences de la motricité > musculoSkeletal Innovative research Lab (mSKIL)
Grisart, Juliane; Artialis SA, Tour GIGA, CHU Sart-Tilman, Liège, Belgium
Kague, Erika ; School of Physiology, Pharmacology, and Neuroscience, University of Bristol, Bristol, UK
Lories, Rik J; Laboratory of Tissue Homeostasis and Disease, Skeletal Biology and Engineering Research Center, Department of Development and Regeneration, KU Leuven, Leuven, Belgium ; Division of Rheumatology, University Hospitals Leuven, Leuven, Belgium
Muller, Marc ; Université de Liège - ULiège > Département des sciences de la vie
Elewaut, Dirk; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium ; Laboratory for Molecular Immunology and Inflammation, Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
Hammond, Chrissy L; School of Physiology, Pharmacology, and Neuroscience, University of Bristol, Bristol, UK
Sanchez, CHRISTELLE ; Université de Liège - ULiège > Département des sciences de la motricité > musculoSkeletal Innovative research Lab (mSKIL)
Henrotin, Yves ; Université de Liège - ULiège > Département des sciences de la motricité > Pathologie générale et physiopathologie - Techniques particulières de kinésithérapie ; Physical Therapy and Rehabilitation Department, Princess Paola Hospital, Vivalia, Marche-en-Famenne, Belgium
Long, H. et al. Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease study 2019. Arthritis Rheumatol. 74, 1172–1183 (2022).
Dell’Isola, A., Allan, R., Smith, S. L., Marreiros, S. S. P. & Steultjens, M. Identification of clinical phenotypes in knee osteoarthritis: a systematic review of the literature. BMC Musculoskelet. Disord. 17, 425 (2016).
Mobasheri, A. et al. Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes. Curr. Opin. Rheumatol. 31, 80–89 (2019).
Loeser, R. F., Goldring, S. R., Scanzello, C. R. & Goldring, M. B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 64, 1697–1707 (2012).
Shabestari, M. et al. Altered protein levels in bone marrow lesions of hip osteoarthritis: analysis by proteomics and multiplex immunoassays. Int. J. Rheum. Dis. 23, 788–799 (2020).
Maruotti, N., Corrado, A. & Cantatore, F. P. Osteoblast role in osteoarthritis pathogenesis. J. Cell Physiol. 232, 2957–2963 (2017).
Stewart, H. L. & Kawcak, C. E. The importance of subchondral bone in the pathophysiology of osteoarthritis. Front. Vet. Sci. 5, 178 (2018).
Sanchez, C. et al. Comparison of secretome from osteoblasts derived from sclerotic versus non-sclerotic subchondral bone in OA: a pilot study. PLoS One 13, e0194591 (2018).
Zappia, J. et al. From translation to protein degradation as mechanisms for regulating biological functions: a review on the SLRP family in skeletal tissues. Biomolecules 10, 80 (2020).
Tashima, T., Nagatoishi, S., Sagara, H., Ohnuma, S. I. & Tsumoto, K. Osteomodulin regulates diameter and alters shape of collagen fibrils. Biochem. Biophys. Res. Commun. 463, 292–296 (2015).
Chen, S. & Birk, D. E. The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly. FEBS J. 280, 2120–2137 (2013).
Chen, X. D., Fisher, L. W., Robey, P. G. & Young, M. F. The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. FASEB J. 18, 948–958 (2004).
Bi, Y. et al. Extracellular matrix proteoglycans control the fate of bone marrow stromal cells*. J. Biol. Chem. 280, 30481–30489 (2005).
Kalamajski, S. & Oldberg, A. The role of small leucine-rich proteoglycans in collagen fibrillogenesis. Matrix Biol. 29, 248–253 (2010).
Schaefer, L. & Iozzo, R. V. Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction *. J. Biol. Chem. 283, 21305–21309 (2008).
Hessle, L. et al. The skeletal phenotype of chondroadherin deficient mice. PLoS One 8, e63080 (2013).
Jepsen, K. J. et al. A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice. J. Biol. Chem. 277, 35532–35540 (2002).
Gill, M. R., Oldberg, Å. & Reinholt, F. P. Fibromodulin-null murine knee joints display increased incidences of osteoarthritis and alterations in tissue biochemistry. Osteoarthr. Cartil. 10, 751–757 (2002).
Corsi, A. et al. Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J. Bone Miner. Res. 17, 1180–1189 (2002).
Ameye, L. et al. Abnormal collagen fibrils in tendons of biglycan/fibromodulin‐deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J. 16, 673–680 (2002).
Nuka, S. et al. Phenotypic characterization of epiphycan-deficient and epiphycan/biglycan double-deficient mice. Osteoarthr. Cartil. 18, 88–96 (2010).
Xu, T. et al. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet. 20, 78–82 (1998).
Chen, X. D., Bian, X., Teslovich, T. M., Stephan, D. A. & Young, M. F. Dissection of the sets of genes that control the behavior of biglycan-deficient pre-osteoblasts using oligonucleotide microarrays. Bone 37, 192–203 (2005).
Kram, V., Kilts, T. M., Bhattacharyya, N., Li, L. & Young, M. F. Small leucine rich proteoglycans, a novel link to osteoclastogenesis. Sci. Rep. 7, 12627 (2017).
Farrán, A. et al. In vivo effect of opticin deficiency in cartilage in a surgically induced mouse model of osteoarthritis. Sci. Rep. 8, 457 (2018).
Wendel, M., Sommarin, Y. & Heinegård, D. Bone matrix proteins: isolation and characterization of a novel cell-binding keratan sulfate proteoglycan (osteoadherin) from bovine bone. J. Cell Biol. 141, 839–847 (1998).
Sommarin, Y., Wendel, M., Shen, Z., Hellman, U. & Heinegård, D. Osteoadherin, a cell-binding keratan sulfate proteoglycan in bone, belongs to the family of leucine-rich repeat proteins of the extracellular matrix. J. Biol. Chem 273, 16723–16729 (1998).
Juchtmans, N. et al. Brief report: Distinct dysregulation of the small leucine-rich repeat protein family in osteoarthritic acetabular labrum compared to articular cartilage. Arthritis Rheumatol. 67, 435–441 (2015).
Lin, W. et al. Osteomodulin positively regulates osteogenesis through interaction with BMP2. Cell Death Dis. 12, 147 (2021).
Rehn, A. P., Cerny, R., Sugars, R. V., Kaukua, N. & Wendel, M. Osteoadherin is upregulated by mature osteoblasts and enhances their in vitro differentiation and mineralization. Calcif. Tissue Int. 82, 454–464 (2008).
Ninomiya, K. et al. Osteoclastic activity induces osteomodulin expression in osteoblasts. Biochem. Biophys. Res. Commun. 362, 460–466 (2007).
Askary, A. et al. Ancient origin of lubricated joints in bony vertebrates. Elife 5, e16415 (2016).
Smeeton, J. et al. Regeneration of jaw joint cartilage in adult zebrafish. Front. Cell Dev. Biol. 9, 777787 (2022).
Gonçalves, I. et al. Osteomodulin gene expression is associated with plaque calcification, stability, and fewer cardiovascular events in the CPIP Cohort. Stroke 29, e79–e84 (2022).
Couble, M. L. et al. Immunodetection of osteoadherin in murine tooth extracellular matrices. Histochem. Cell Biol. 121, 47–53 (2004).
Buchaille, R., Couble, M. L., Magloire, H. & Bleicher, F. Expression of the small leucine-rich proteoglycan osteoadherin/osteomodulin in human dental pulp and developing rat teeth. Bone 27, 265–270 (2000).
Skenteris, N. T. et al. Osteomodulin is a novel gene in cardiovascular calcification. Atherosclerosis 331, e93 (2021).
Skenteris, N. T. et al. Osteomodulin attenuates smooth muscle cell osteogenic transition in vascular calcification. Clin. Transl. Med. 12, 682 (2022).
Fan, X. et al. The deterioration of calcified cartilage integrity reflects the severity of osteoarthritis—a structural, molecular, and biochemical analysis. FASEB J. 36, 22142 (2022).
Hayami, T. et al. Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 38, 234–243 (2006).
Deng, B. et al. Quantitative study on morphology of calcified cartilage zone in OARSI 0∼4 cartilage from osteoarthritic knees. Curr. Res. Transl. Med. 64, 149–154 (2016).
Poulet, B. et al. Modifications of gait as predictors of natural osteoarthritis progression in Str/Ort mice. Arthritis Rheumatol. 66, 1832–1842 (2014).
Muramatsu, Y. et al. Preventive effects of hyaluronan from deterioration of gait parameters in surgically induced mice osteoarthritic knee model. Osteoarthr. Cartil. 22, 831–835 (2014).
Makii, Y. et al. Alteration of gait parameters in a mouse model of surgically induced knee osteoarthritis. J. Orthop. Surg. 26, 2309499018768017 (2018).
Pesesse, L. et al. Bone sialoprotein as a potential key factor implicated in the pathophysiology of osteoarthritis. Osteoarthr. Cartil. 22, 547–556 (2014).
Bergen, D. J. M. et al. Regenerating zebrafish scales express a subset of evolutionary conserved genes involved in human skeletal disease. BMC Biol. 20, 21 (2022).
Salbach, J. et al. The effect of the degree of sulfation of glycosaminoglycans on osteoclast function and signaling pathways. Biomaterials 33, 8418–8429 (2012).
Sugars, R. V., Olsson, M.-L., Marchner, S., Hultenby, K. & Wendel, M. The glycosylation profile of osteoadherin alters during endochondral bone formation. Bone 53, 459–467 (2013).
Geurts, J. et al. Elevated marrow inflammatory cells and osteoclasts in subchondral osteosclerosis in human knee osteoarthritis. J. Orthop. Res. 34, 262–269 (2016).
Zhen, G. et al. Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat. Med. 19, 704–712 (2013).
Dai, G. et al. Osteocyte TGFβ1-Smad2/3 is positively associated with bone turnover parameters in subchondral bone of advanced osteoarthritis. Int. J. Mol. Med. 46, 167–178 (2020).
Glasson, S. S., Blanchet, T. J. & Morris, E. A. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthr. Cartil. 15, 1061–1069 (2007).
Glasson, S. S., Chambers, M. G., van den Berg, W. B. & Little, C. B. The OARSI histopathology initiative—recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthr. Cartil. 18, S17–S23 (2010).
Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).
Aleström, P. et al. Zebrafish: housing and husbandry recommendations. Lab Anim. 54, 213–224 (2020).
Bussmann, J. & Schulte-Merker, S. Rapid BAC selection for tol2-mediated transgenesis in zebrafish. Development 138, 4327–4332 (2011).
Walker, M. B. & Kimmel, C. B. A two-color acid-free cartilage and bone stain for zebrafish larvae. Biotech. Histochem. 82, 23–28 (2007).
Hauptmann G. & Gerster T. Two-color whole-mount in situ hybridization to vertebrate and Drosophila embryos. Trends Genet. 10, 266 (1994).
Rasband, W. S. ImageJ: image processing and analysis in Java. Astrophysics Source Code Library (2012).
Ethiraj, L. P. et al. Colorimetric and fluorescent TRAP assays for visualising and quantifying fish osteoclast activity. Eur. J. Histochem. 66, 3369 (2022).
Tarasco, M., Cordelières, F. P., Cancela, M. L. & Laizé, V. ZFBONE: an ImageJ toolset for semi-automatic analysis of zebrafish bone structures. Bone 138, 115480 (2020).
Sanchez, C. et al. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1β and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthr. Cartil. 13, 979–987 (2005).
Sanchez, C. et al. Curcuma longa and Boswellia serrata extracts modulate different and complementary pathways on human chondrocytes in vitro: deciphering of a transcriptomic study. Front. Pharm. 13, 931914 (2022).
Jepsen, K. J., Silva, M. J., Vashishth, D., Guo, X. E. & Van Der Meulen, M. C. H. Establishing biomechanical mechanisms in mouse models: practical guidelines for systematically evaluating phenotypic changes in the diaphyses of long bones. J. Bone Miner. Res. 30, 951–966 (2015).
